RENI BENJAMIN, PhD, Dr. Reni Benjamin is a Senior Biotechnology Analyst
at Rodman and Renshaw. Prior to joining Rodman, Dr. Benjamin was an
associate analyst in Needham and Company’s biotechnology equity research
department. He earned his doctorate in Biochemistry by discovering and
characterizing a novel gene implicated in germ cell development. His
expertise includes biochemistry, functional genomics, gene therapy and
molecular biology. Dr. Benjamin has presented at various regional and
international conferences and published in peer-reviewed journals.
Additionally, he has been cited in a variety of sources including the
Wall Street Journal, Dow Jones Newswire, and Bloomberg. Dr. Benjamin
received his Ph.D. from the University of Alabama at Birmingham and his
Bachelors of Science degree in Biology from Allegheny College.